Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Unknown Primary × Topotecan × 1 year × Clear all

Sponsor

Conditions

Small Cell Lung Carcinoma 13 Ovarian Neoplasms 12 Neuroblastoma 10 Fallopian Tube Neoplasms 8 Neoplasms 5 Uterine Cervical Neoplasms 4 Ganglioneuroblastoma 4 Carcinoma, Ovarian Epithelial 4 Brain Neoplasms 4 Retinoblastoma 3 Sarcoma, Ewing 2 Recurrence 2 Medulloblastoma 2 Leukemia, Myeloid, Acute 2 Glioma 2 Carcinoma, Non-Small-Cell Lung 2 Wilms Tumor 1 Thrombocythemia, Essential 1 SCLC, Extensive Stage 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Retinal Neoplasms 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pleuropulmonary blastoma 1 Pediatric Brain Tumor 1 Osteosarcoma 1 Neoplasm Metastasis 1 Myelodysplastic-Myeloproliferative Diseases 1 Meningioma 1

Interventions

pembrolizumab 2 atezolizumab 2 zenocutuzumab 1 sintilimab 1 pertuzumab 1 pemigatinib 1 olaparib 1 ivosidenib 1 ipatasertib 1 entrectinib 1 cobimetinib 1 alectinib 1 Whole Genome Sequencing 1 Vemurafenib 1 Transurethral Resection of Prostate 1 Specimen Handling 1 Sequence Analysis, RNA 1 Radiosurgery 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 HhAntag691 1 Genetic Testing 1 Genetic Profile 1 Gemcitabine 1 Fluorodeoxyglucose F18 1 FAPI-46 1 Erlotinib Hydrochloride 1 Cisplatin 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡